TC
ENZN

TFS Capital’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

TFS Capital’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-52,031
Closed -$62K – 1186
2015
Q2 		$62K Buy
+52,031
New +$66.3K 0.01% 843
2014
Q1 		– Sell
-41,314
Closed -$48K – 1774
2013
Q4 		$48K Sell
41,314
-37,397
-48% -$57.6K ﹤0.01% 1429
2013
Q3 		$132K Sell
78,711
-158,986
-67% -$294K 0.01% 1335
2013
Q2 		$475K Buy
+237,697
New +$696K 0.02% 924

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

TFS Capital's ENZN Position: Q3 2015 in Review

TFS Capital sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2015, closing a stake of 52,031 shares — an estimated $62K sold.

TFS Capital first reported a position in ENZN in Q2 2013 and held it in 4 quarters. The position peaked at $475K in Q2 2013. 53 funds tracked by Wall St. Rank hold ENZN as of Q3 2015.

  • TFS Capital reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2015 after selling out during the quarter.
  • TFS Capital sold 52,031 ENZON PHARMACEUTICALS INC shares in Q3 2015, an estimated $62K.
  • TFS Capital first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • TFS Capital's ENZON PHARMACEUTICALS INC position peaked at $475K in Q2 2013.
  • 53 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2015.

Based on TFS Capital's 13F filing for Q3 2015, filed 3 Nov 2015.